Abstract: The present invention provides a compound of Formula I: (I) wherein R1 is H, halogen, C1-C3 alkyl, or C1-C3 alkoxy; R2 is H or halogen; and X is O, OCH2, or CH2, or a pharmaceutically acceptable salt thereof, wherein the compound of Formula I, or pharmaceutically acceptable salt thereof is useful for treating autoimmune and inflammatory diseases, such as atopic dermatitis, rheumatoid arthritis, and lupus nephritis.
| # | Name | Date |
|---|---|---|
| 1 | 202317056457-STATEMENT OF UNDERTAKING (FORM 3) [23-08-2023(online)].pdf | 2023-08-23 |
| 2 | 202317056457-REQUEST FOR EXAMINATION (FORM-18) [23-08-2023(online)].pdf | 2023-08-23 |
| 3 | 202317056457-POWER OF AUTHORITY [23-08-2023(online)].pdf | 2023-08-23 |
| 4 | 202317056457-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [23-08-2023(online)].pdf | 2023-08-23 |
| 5 | 202317056457-FORM 18 [23-08-2023(online)].pdf | 2023-08-23 |
| 6 | 202317056457-FORM 1 [23-08-2023(online)].pdf | 2023-08-23 |
| 7 | 202317056457-DECLARATION OF INVENTORSHIP (FORM 5) [23-08-2023(online)].pdf | 2023-08-23 |
| 8 | 202317056457-COMPLETE SPECIFICATION [23-08-2023(online)].pdf | 2023-08-23 |
| 9 | 202317056457-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [23-08-2023(online)].pdf | 2023-08-23 |
| 10 | 202317056457-Proof of Right [19-09-2023(online)].pdf | 2023-09-19 |
| 11 | 202317056457-FORM 3 [06-02-2024(online)].pdf | 2024-02-06 |
| 12 | 202317056457-FER.pdf | 2025-05-05 |
| 13 | 202317056457-FORM-26 [13-06-2025(online)].pdf | 2025-06-13 |
| 14 | 202317056457-FORM 3 [13-06-2025(online)].pdf | 2025-06-13 |
| 1 | 202317056457_SearchStrategyNew_E_SearchHistoryE_28-04-2025.pdf |